Innova Captab Q2 FY27 Revenue Rises 30.5% to ₹496.3 Crore

Innova Captab Limited reported Q2 FY27 consolidated revenue of ₹496.3 crore, up 30.5% year on year, while net profit increased 43.0% to ₹42.4 crore for the quarter ended 30 September 2026. The results show continued growth across the company’s CDMO and branded generics businesses, alongside a modest sequential rise in revenue.

What did Innova Captab report for Q2 FY27?

Innova Captab reported consolidated revenue from operations of ₹496.3 crore in Q2 FY27, compared with the corresponding quarter a year earlier, representing growth of 30.5%. Revenue was also 5.4% higher than the preceding quarter. Consolidated EBITDA rose 29.2% year on year to ₹72.4 crore.

Consolidated profit after tax, or PAT, was ₹42.4 crore, an increase of 43.0% from Q2 FY26. On a sequential basis, however, PAT declined 3.9%. The reported EBITDA margin was 14.6%, while the PAT margin stood at 8.5%. The company’s results are unaudited consolidated figures for the three months ended 30 September 2026.

How did the board and auditors address the results?

Innova Captab’s board approved the unaudited standalone and consolidated financial results for the quarter and half year ended 30 September 2026. The company had informed the NSE on 5 November that its board would meet on 13 November to consider the results.

The auditors issued unmodified limited-review conclusions on the financial statements. For the consolidated review, the auditor relied on another auditor’s report relating to one subsidiary. This is stated in the review documentation, while the conclusion on the reported results remained unmodified. No exceptional items were reported in the standalone Q2 results.

How did Innova Captab perform in the first half of FY27?

Innova Captab’s consolidated revenue from operations for H1 FY27 rose 32.1% year on year to ₹967.2 crore. EBITDA increased 31.0% to ₹147.5 crore, and PAT grew 42.6% to ₹86.5 crore for the six months ended 30 September 2026.

The H1 EBITDA margin was 15.3% and the PAT margin was 8.9%. Operating cash flow on a standalone basis improved to ₹72.6 crore during the first half. The half-year figures provide a broader view of business momentum after the company had reported revenue of about ₹471 crore and net profit of about ₹44 crore in the June 2026 quarter.

What were the standalone results and operating metrics?

Innova Captab posted standalone Q2 FY27 revenue of ₹404.8 crore and standalone net profit of ₹32.0 crore. The standalone operating margin was 13.1%, according to the reported summary. The company did not report exceptional items in the standalone statement for the quarter.

The gap between standalone and consolidated revenue reflects the inclusion of group operations in the consolidated accounts. Investors tracking the company’s quarterly execution can therefore consider both sets of figures, while using the consolidated results for the broader group-level financial performance disclosed by Innova Captab.

Why do the Q2 results matter for Innova Captab investors?

The Q2 result matters because Innova Captab maintained revenue growth above 30% year on year after reporting 34% growth in the June 2026 quarter. Consolidated revenue moved from about ₹471 crore in Q1 FY27 to ₹496.3 crore in Q2 FY27, indicating sequential expansion through the first half of the financial year.

The earnings release linked business momentum to the CDMO and branded generics segments. Management said it remains focused on strengthening CDMO positioning, expanding branded generics and increasing manufacturing capacity. In September 2026, the board approved a ₹50 crore land acquisition for a future facility expansion, indicating that capacity development remains part of the company’s disclosed plans.

What should investors monitor after the Q2 FY27 announcement?

Investors should monitor the company’s commentary on capacity expansion, CDMO business development and branded-generics execution following the Q2 announcement. Revenue and EBITDA have grown strongly year on year, but the disclosed Q2 EBITDA margin of 14.6% was below the 15.3% reported for H1 FY27, making future margin disclosures relevant to financial tracking.

Innova Captab has scheduled a virtual analyst and investor meeting for 16 November 2026 at 11:00 AM IST to discuss the unaudited Q2 and H1 FY27 results. Managing Director Vinay Lohariwala and CFO Lokesh Bhasin are scheduled to present at the meeting. Investors may look for further detail on operations and the timeline for the company’s approved expansion initiatives.

Conclusion

Innova Captab delivered consolidated Q2 FY27 revenue of ₹496.3 crore and PAT of ₹42.4 crore, extending the growth seen in the first quarter. The 30.5% rise in revenue and 43.0% increase in PAT supported H1 revenue of ₹967.2 crore and H1 PAT of ₹86.5 crore, while the board’s approval and unmodified review conclusions completed the reporting process.

The next disclosed event is the virtual analyst and investor meeting on 16 November 2026. Investors will watch for management’s discussion of CDMO and branded-generics momentum, manufacturing-capacity plans and the ₹50 crore land acquisition approved for future expansion.